Business Context and Reporting Period
This Form 8-K Current Report was filed by enGene Therapeutics Inc. (formerly enGene Holdings Inc.) on April 7, 2026. The report details a corporate name change effective April 8, 2026, and the corresponding amendment to the Company's Articles of Incorporation. The Company is incorporated in British Columbia and its securities trade on The Nasdaq Stock Market LLC.
Financial Metrics
This filing is a current report regarding a corporate governance event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
- Corporate Name Change: The Company changed its name from enGene Holdings Inc. to enGene Therapeutics Inc., effective April 8, 2026.
- Articles Amendment: The Board of Directors amended the Company's Articles to reflect the new name. No other changes were made to the Articles.
- Trading Symbols: Common shares and warrants will continue to trade under the ticker symbols "ENGN" and "ENGNW," respectively. The warrant exercise price remains $11.50 per share.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, or specific risk factors. The document focuses solely on the procedural execution of the name change and the associated regulatory filings. A press release announcing the name change was issued on April 7, 2026, and is included as an exhibit but is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Verify the effective date of the name change (April 8, 2026) and confirm the updated corporate name in trading systems.
- Confirm that the ticker symbols (ENGN and ENGNW) remain unchanged despite the name alteration.
- Review the attached Notice of Alteration and amended Articles (Exhibits 3.1 and 3.2) to ensure no other corporate bylaws were inadvertently modified.
- Note that this filing contains no financial data; investors should refer to the most recent 10-K or 10-Q for financial health metrics.